We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
Cap. Flow
-$4B
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.66B
2
BABA icon
Alibaba
BABA
+$881M
3
INTC icon
Intel
INTC
+$783M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$783M
5
LIN icon
Linde
LIN
+$667M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Financials 13%
3 Consumer Discretionary 12.7%
4 Healthcare 12.61%
5 Communication Services 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BV icon
2451
BrightView Holdings
BV
$1.07B
$3.27M ﹤0.01%
202,584
+16,289
+9% +$286K
SY
2452
So-Young International
SY
$219M
$3.26M ﹤0.01%
339,606
+3,200
+1% +$29.5K
GOOD
2453
Gladstone Commercial Corp
GOOD
$627M
$3.25M ﹤0.01%
144,039
-3,125
-2% -$66.8K
TCRT icon
2454
Alaunos Therapeutics
TCRT
$4.86M
$3.23M ﹤0.01%
8,152
+2,326
+40% +$1.09M
ACRS icon
2455
Aclaris Therapeutics
ACRS
$869M
$3.23M ﹤0.01%
+183,787
New +$4.17M
CCF
2456
DELISTED
Chase Corporation
CCF
$3.22M ﹤0.01%
31,422
+2,899
+10% +$321K
CTBI icon
2457
Community Trust Bancorp
CTBI
$1.41B
$3.21M ﹤0.01%
79,622
-1,446
-2% -$63.4K
CRSR icon
2458
Corsair Gaming
CRSR
$1.55B
$3.21M ﹤0.01%
96,441
-55,293
-36% -$1.82M
CLW icon
2459
Clearwater Paper
CLW
$376M
$3.2M ﹤0.01%
110,477
+32,145
+41% +$1M
PLRX icon
2460
Pliant Therapeutics
PLRX
$65M
$3.2M ﹤0.01%
109,937
+29,660
+37% +$923K
GTS
2461
DELISTED
Triple-S Management Corporation
GTS
$3.2M ﹤0.01%
143,720
-1,526
-1% -$37.9K
DYN icon
2462
Dyne Therapeutics
DYN
$4.9B
$3.19M ﹤0.01%
151,731
+110,223
+266% +$2.07M
PHAT icon
2463
Phathom Pharmaceuticals
PHAT
$692M
$3.19M ﹤0.01%
94,085
+28,129
+43% +$1.01M
CGEM icon
2464
Cullinan Oncology
CGEM
$1.14B
$3.18M ﹤0.01%
123,370
+73,634
+148% +$2.26M
HCKT icon
2465
Hackett Group
HCKT
$287M
$3.17M ﹤0.01%
175,906
-3,118
-2% -$54.2K
AGTI
2466
DELISTED
Agiliti Inc
AGTI
$3.17M ﹤0.01%
+144,955
New +$2.77M
VXRT
2467
DELISTED
Vaxart
VXRT
$3.17M ﹤0.01%
423,039
+222,868
+111% +$1.56M
EGIO
2468
DELISTED
Edgio, Inc. Common Stock
EGIO
$3.15M ﹤0.01%
24,973
+1,989
+9% +$263K
CLBK icon
2469
Columbia Financial
CLBK
$1.13B
$3.14M ﹤0.01%
182,166
-33,100
-15% -$583K
CRMT icon
2470
America's Car Mart
CRMT
$26.9M
$3.11M ﹤0.01%
21,962
-4,012
-15% -$600K
STOK icon
2471
Stoke Therapeutics
STOK
$2.11B
$3.11M ﹤0.01%
92,450
+40,860
+79% +$1.44M
AMTB icon
2472
Amerant Bancorp
AMTB
$1.13B
$3.11M ﹤0.01%
145,485
+33,453
+30% +$701K
GRC icon
2473
Gorman-Rupp
GRC
$2.21B
$3.1M ﹤0.01%
90,106
+18,201
+25% +$633K
GOEV
2474
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$3.1M ﹤0.01%
+678
New +$2.74M
PENG
2475
Penguin Solutions Inc
PENG
$2.99B
$3.1M ﹤0.01%
129,896
+30,488
+31% +$735K

Similar funds

Nuveen's Q2 2021 Portfolio in Review

As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
  • Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
  • Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
  • Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
  • Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
  • Nuveen opened 323 new positions and closed 323 in Q2 2021.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.